المؤلفون: Cristina Bagacean, Adrian Tempescul, David Ternant, Anne Banet, Nathalie Douet-Guilbert, Anne Bordron, Boutahar Bendaoud, Hussam Saad, Mihnea Zdrenghea, Christian Berthou, Gilles Paintaud, Yves Renaudineau

المصدر: Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-5 (2019)

مصطلحات موضوعية: Chronic lymphocytic leukemia, Anti-CD20 monoclonal antibody, Rituximab, Pharmacokinetics, Clearance, 17p deletion, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: http://link.springer.com/article/10.1186/s40425-019-0509-0; https://doaj.org/toc/2051-1426

URL الوصول: https://doaj.org/article/874ce61e568a46c38d593ea120b275c2

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Abdeslam EK; Biological Engineering Laboratory, Faculty of Sciences and Techniques, Sultan Moulay Slimane University, Beni Mellal, Morocco. Electronic address: elkardoudiabdeslam@gmail.com., Ahmed C; Biological Engineering Laboratory, Faculty of Sciences and Techniques, Sultan Moulay Slimane University, Beni Mellal, Morocco. Electronic address: ahmed.chetoui@usms.ma., Kamal K; Biological Engineering Laboratory, Faculty of Sciences and Techniques, Sultan Moulay Slimane University, Beni Mellal, Morocco. Electronic address: kamal.kaoutar@edu.uca.ac.ma., Rachid L; Biological Engineering Laboratory, Faculty of Sciences and Techniques, Sultan Moulay Slimane University, Beni Mellal, Morocco. Electronic address: r.lotfi@usms.ma., Keltoum B; Biological Engineering Laboratory, Faculty of Sciences and Techniques, Sultan Moulay Slimane University, Beni Mellal, Morocco. Electronic address: keltoumdiet@hotmail.com., Soufiane E; Biological Engineering Laboratory, Faculty of Sciences and Techniques, Sultan Moulay Slimane University, Beni Mellal, Morocco; Mohamed VI Hospital University, BP 2360 Principal, Avenue Ibn Sina, Marrakesh, Morocco. Electronic address: soufiane.lueur@gmail.com., Mohamed N; Biological Engineering Laboratory, Faculty of Sciences and Techniques, Sultan Moulay Slimane University, Beni Mellal, Morocco. Electronic address: mnajimi1@yahoo.fr., Fatiha C; Biological Engineering Laboratory, Faculty of Sciences and Techniques, Sultan Moulay Slimane University, Beni Mellal, Morocco. Electronic address: f.chigr@usms.ma.

المصدر: Annales de cardiologie et d'angeiologie [Ann Cardiol Angeiol (Paris)] 2023 Oct; Vol. 72 (4), pp. 101607. Date of Electronic Publication: 2023 Jun 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: France NLM ID: 0142167 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1768-3181 (Electronic) Linking ISSN: 00033928 NLM ISO Abbreviation: Ann Cardiol Angeiol (Paris) Subsets: MEDLINE

مواضيع طبية MeSH: Sedentary Behavior* , Hypertension*/epidemiology, Humans ; Male ; Adult ; Middle Aged ; Female ; Cross-Sectional Studies ; Exercise ; Time Factors

المؤلفون: Bagacean C; U1227 B Lymphocytes and Autoimmunity, University of Brest; INSERM; networks IC-CGO and REpiCGO from 'Canceropole Grand Ouest', Brest, France. cristina.bagacean@univ-brest.fr.; Department of Hematology, Brest University Medical School Hospital, 5 Foch Avenue, BP 824, F-29609, Brest, France. cristina.bagacean@univ-brest.fr.; Laboratory of Immunology and Immunotherapy, Brest University Medical School Hospital, Brest, France. cristina.bagacean@univ-brest.fr., Tempescul A; U1227 B Lymphocytes and Autoimmunity, University of Brest; INSERM; networks IC-CGO and REpiCGO from 'Canceropole Grand Ouest', Brest, France.; Department of Hematology, Brest University Medical School Hospital, 5 Foch Avenue, BP 824, F-29609, Brest, France., Ternant D; University of Tours, EA 7501 Innovation and Cell Targeting Group, CHRU de Tours, Laboratory of Pharmacology-Toxicology, Tours, France., Banet A; Department of Hematology, Brest University Medical School Hospital, 5 Foch Avenue, BP 824, F-29609, Brest, France., Douet-Guilbert N; Laboratory of Cytogenetics, Brest University Medical School Hospital, Brest, France., Bordron A; U1227 B Lymphocytes and Autoimmunity, University of Brest; INSERM; networks IC-CGO and REpiCGO from 'Canceropole Grand Ouest', Brest, France., Bendaoud B; Laboratory of Immunology and Immunotherapy, Brest University Medical School Hospital, Brest, France., Saad H; Department of Hematology, Brest University Medical School Hospital, 5 Foch Avenue, BP 824, F-29609, Brest, France., Zdrenghea M; 'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania., Berthou C; U1227 B Lymphocytes and Autoimmunity, University of Brest; INSERM; networks IC-CGO and REpiCGO from 'Canceropole Grand Ouest', Brest, France.; Department of Hematology, Brest University Medical School Hospital, 5 Foch Avenue, BP 824, F-29609, Brest, France., Paintaud G; University of Tours, EA 7501 Innovation and Cell Targeting Group, CHRU de Tours, Laboratory of Pharmacology-Toxicology, Tours, France., Renaudineau Y; Laboratory of Immunology and Immunotherapy, Brest University Medical School Hospital, Brest, France.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2019 Jan 29; Vol. 7 (1), pp. 22. Date of Electronic Publication: 2019 Jan 29.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Chromosome Deletion* , Chromosomes, Human, Pair 17*, Antineoplastic Agents, Immunological/*pharmacokinetics , Leukemia, Lymphocytic, Chronic, B-Cell/*drug therapy , Leukemia, Lymphocytic, Chronic, B-Cell/*genetics , Rituximab/*pharmacokinetics, Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents, Immunological/therapeutic use ; Female ; Genetic Variation ; Humans ; Leukemia, Lymphocytic, Chronic, B-Cell/diagnosis ; Male ; Middle Aged ; Molecular Targeted Therapy ; Neoplasm Staging ; Prognosis ; Rituximab/therapeutic use ; Tumor Suppressor Protein p53/genetics

المؤلفون: Bordron A; U1227 B Lymphocytes and Autoimmunity, Université de Brest, INSERM, IBSAM, Labex IGO, Networks IC-CGO and REpiCGO from 'Canceropole Grand Ouest, Brest, France., Bagacean C; U1227 B Lymphocytes and Autoimmunity, Université de Brest, INSERM, IBSAM, Labex IGO, Networks IC-CGO and REpiCGO from 'Canceropole Grand Ouest, Brest, France.; Laboratory of Immunology and Immunotherapy, CHRU Brest, Hôpital Morvan, Brest, France., Mohr A; U1227 B Lymphocytes and Autoimmunity, Université de Brest, INSERM, IBSAM, Labex IGO, Networks IC-CGO and REpiCGO from 'Canceropole Grand Ouest, Brest, France., Tempescul A; U1227 B Lymphocytes and Autoimmunity, Université de Brest, INSERM, IBSAM, Labex IGO, Networks IC-CGO and REpiCGO from 'Canceropole Grand Ouest, Brest, France.; Department of Haematology, CHRU Brest, Hôpital Morvan, Brest, France., Bendaoud B; U1227 B Lymphocytes and Autoimmunity, Université de Brest, INSERM, IBSAM, Labex IGO, Networks IC-CGO and REpiCGO from 'Canceropole Grand Ouest, Brest, France.; Laboratory of Immunology and Immunotherapy, CHRU Brest, Hôpital Morvan, Brest, France., Deshayes S; U1227 B Lymphocytes and Autoimmunity, Université de Brest, INSERM, IBSAM, Labex IGO, Networks IC-CGO and REpiCGO from 'Canceropole Grand Ouest, Brest, France., Dalbies F; Department of Haematology, CHRU Brest, Hôpital Morvan, Brest, France., Buors C; Laboratory of Haematology, CHRU Brest, Hôpital Morvan, Brest, France., Saad H; Department of Haematology, CHRU Brest, Hôpital Morvan, Brest, France., Berthou C; U1227 B Lymphocytes and Autoimmunity, Université de Brest, INSERM, IBSAM, Labex IGO, Networks IC-CGO and REpiCGO from 'Canceropole Grand Ouest, Brest, France.; Department of Haematology, CHRU Brest, Hôpital Morvan, Brest, France., Pers JO; U1227 B Lymphocytes and Autoimmunity, Université de Brest, INSERM, IBSAM, Labex IGO, Networks IC-CGO and REpiCGO from 'Canceropole Grand Ouest, Brest, France., Renaudineau Y; U1227 B Lymphocytes and Autoimmunity, Université de Brest, INSERM, IBSAM, Labex IGO, Networks IC-CGO and REpiCGO from 'Canceropole Grand Ouest, Brest, France.; Laboratory of Immunology and Immunotherapy, CHRU Brest, Hôpital Morvan, Brest, France.

المصدر: Oncotarget [Oncotarget] 2018 Aug 03; Vol. 9 (60), pp. 31590-31605. Date of Electronic Publication: 2018 Aug 03 (Print Publication: 2018).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: eCollection Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: PubMed not MEDLINE

المؤلفون: Gazeau P; Laboratory of Immunology and Immunotherapy, CHU Morvan, Brest, France.; Unit of Rheumatology, CHRU Brest-Carhaix, Hôpital Cavale Blanche, Brest, France., Alegria GC; Laboratory of Immunology and Immunotherapy, CHU Morvan, Brest, France.; Unit of Rheumatology, CHRU Brest-Carhaix, Hôpital Cavale Blanche, Brest, France., Devauchelle-Pensec V; Unit of Rheumatology, CHRU Brest-Carhaix, Hôpital Cavale Blanche, Brest, France.; INSERM U1227, LabEx IGO 'Immunotherapy Graft Oncolog', Réseau épigénétique et réseau canaux ioniques du Cancéropole Grand Ouest, European University of Brittany, Brest, France., Jamin C; Laboratory of Immunology and Immunotherapy, CHU Morvan, Brest, France.; INSERM U1227, LabEx IGO 'Immunotherapy Graft Oncolog', Réseau épigénétique et réseau canaux ioniques du Cancéropole Grand Ouest, European University of Brittany, Brest, France., Lemerle J; Laboratory of Immunology and Immunotherapy, CHU Morvan, Brest, France., Bendaoud B; Laboratory of Immunology and Immunotherapy, CHU Morvan, Brest, France.; INSERM U1227, LabEx IGO 'Immunotherapy Graft Oncolog', Réseau épigénétique et réseau canaux ioniques du Cancéropole Grand Ouest, European University of Brittany, Brest, France., Brooks WH; Department of Chemistry, University of South Florida, Tampa, FL, USA., Saraux A; Unit of Rheumatology, CHRU Brest-Carhaix, Hôpital Cavale Blanche, Brest, France.; INSERM U1227, LabEx IGO 'Immunotherapy Graft Oncolog', Réseau épigénétique et réseau canaux ioniques du Cancéropole Grand Ouest, European University of Brittany, Brest, France., Cornec D; Unit of Rheumatology, CHRU Brest-Carhaix, Hôpital Cavale Blanche, Brest, France.; INSERM U1227, LabEx IGO 'Immunotherapy Graft Oncolog', Réseau épigénétique et réseau canaux ioniques du Cancéropole Grand Ouest, European University of Brittany, Brest, France., Renaudineau Y; Laboratory of Immunology and Immunotherapy, CHU Morvan, Brest, France. yves.renaudineau@univ-brest.fr.; INSERM U1227, LabEx IGO 'Immunotherapy Graft Oncolog', Réseau épigénétique et réseau canaux ioniques du Cancéropole Grand Ouest, European University of Brittany, Brest, France. yves.renaudineau@univ-brest.fr.

المصدر: Clinical reviews in allergy & immunology [Clin Rev Allergy Immunol] 2017 Oct; Vol. 53 (2), pp. 166-176.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Humana Press Country of Publication: United States NLM ID: 9504368 Publication Model: Print Cited Medium: Internet ISSN: 1559-0267 (Electronic) Linking ISSN: 10800549 NLM ISO Abbreviation: Clin Rev Allergy Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Abatacept/*therapeutic use , Arthritis, Rheumatoid/*drug therapy , B-Lymphocyte Subsets/*immunology , B-Lymphocytes/*immunology , T-Lymphocytes/*immunology, Adult ; Aged ; Arthritis, Rheumatoid/immunology ; CTLA-4 Antigen/antagonists & inhibitors ; Female ; Humans ; Immunologic Memory ; Lymphocyte Activation ; Lymphocyte Count ; Male ; Middle Aged ; Retrospective Studies ; Treatment Outcome

المؤلفون: Simonin L; Laboratory of Immunology and Immunotherapy, Hôpital Morvan, University Hospital of Brest, Brest, France.; INSERM ESPRI, ERI29/EA2216, LabEx IGO 'Immunotherapy Graft Oncology', Réseau épigénétique et réseau canaux ioniques du Cancéropole Grand Ouest, European University of Brittany, Brest, France.; Department of Internal Medicine and Chest Diseases, European University of Brittany, EA3878 (G.E.T.B.O, Hôpital Cavale Blanche, University Hospital of Brest, Brest, France., Pasquier E; Department of Internal Medicine and Chest Diseases, European University of Brittany, EA3878 (G.E.T.B.O, Hôpital Cavale Blanche, University Hospital of Brest, Brest, France., Leroyer C; Department of Internal Medicine and Chest Diseases, European University of Brittany, EA3878 (G.E.T.B.O, Hôpital Cavale Blanche, University Hospital of Brest, Brest, France., Cornec D; INSERM ESPRI, ERI29/EA2216, LabEx IGO 'Immunotherapy Graft Oncology', Réseau épigénétique et réseau canaux ioniques du Cancéropole Grand Ouest, European University of Brittany, Brest, France.; Unit of Rheumatology, Hôpital Cavale Blanche, University Hospital of Brest, Brest, France., Lemerle J; Laboratory of Immunology and Immunotherapy, Hôpital Morvan, University Hospital of Brest, Brest, France., Bendaoud B; Laboratory of Immunology and Immunotherapy, Hôpital Morvan, University Hospital of Brest, Brest, France.; INSERM ESPRI, ERI29/EA2216, LabEx IGO 'Immunotherapy Graft Oncology', Réseau épigénétique et réseau canaux ioniques du Cancéropole Grand Ouest, European University of Brittany, Brest, France., Hillion S; Laboratory of Immunology and Immunotherapy, Hôpital Morvan, University Hospital of Brest, Brest, France.; INSERM ESPRI, ERI29/EA2216, LabEx IGO 'Immunotherapy Graft Oncology', Réseau épigénétique et réseau canaux ioniques du Cancéropole Grand Ouest, European University of Brittany, Brest, France., Pers JO; INSERM ESPRI, ERI29/EA2216, LabEx IGO 'Immunotherapy Graft Oncology', Réseau épigénétique et réseau canaux ioniques du Cancéropole Grand Ouest, European University of Brittany, Brest, France., Couturaud F; Department of Internal Medicine and Chest Diseases, European University of Brittany, EA3878 (G.E.T.B.O, Hôpital Cavale Blanche, University Hospital of Brest, Brest, France., Renaudineau Y; Laboratory of Immunology and Immunotherapy, Hôpital Morvan, University Hospital of Brest, Brest, France. yves.renaudineau@univ-brest.fr.; INSERM ESPRI, ERI29/EA2216, LabEx IGO 'Immunotherapy Graft Oncology', Réseau épigénétique et réseau canaux ioniques du Cancéropole Grand Ouest, European University of Brittany, Brest, France. yves.renaudineau@univ-brest.fr.

المصدر: Clinical reviews in allergy & immunology [Clin Rev Allergy Immunol] 2017 Aug; Vol. 53 (1), pp. 14-27.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Humana Press Country of Publication: United States NLM ID: 9504368 Publication Model: Print Cited Medium: Internet ISSN: 1559-0267 (Electronic) Linking ISSN: 10800549 NLM ISO Abbreviation: Clin Rev Allergy Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Lymphocyte Count*, Antiphospholipid Syndrome/*blood , Antiphospholipid Syndrome/*immunology , Lymphocyte Subsets/*immunology , Venous Thromboembolism/*blood , Venous Thromboembolism/*immunology, Animals ; Antiphospholipid Syndrome/diagnosis ; Autoimmunity ; B-Lymphocyte Subsets/immunology ; B-Lymphocyte Subsets/metabolism ; Biomarkers ; Humans ; Immunophenotyping ; Lymphocyte Subsets/metabolism ; Serologic Tests ; T-Lymphocyte Subsets/immunology ; T-Lymphocyte Subsets/metabolism ; Venous Thromboembolism/diagnosis

المؤلفون: Achour A; Université de Brest, INSERM U1227, Lymphocytes B et Autoimmunité, and LabEx IGO, Brest, France., Simon Q; Université de Brest, INSERM U1227, Lymphocytes B et Autoimmunité, and LabEx IGO, Brest, France., Mohr A; Université de Brest, INSERM U1227, Lymphocytes B et Autoimmunité, and LabEx IGO, Brest, France., Séité JF; Université de Brest, INSERM U1227, Lymphocytes B et Autoimmunité, and LabEx IGO, Brest, France; CHRU Morvan, Laboratoire d'Immunologie, Brest, France., Youinou P; Université de Brest, INSERM U1227, Lymphocytes B et Autoimmunité, and LabEx IGO, Brest, France; CHRU Morvan, Laboratoire d'Immunologie, Brest, France., Bendaoud B; CHRU Morvan, Laboratoire d'Immunologie, Brest, France., Ghedira I; Faculty of Pharmacy, Department of Immunology, Research Unit (03/UR/07-02), Monastir, Tunisia., Pers JO; Université de Brest, INSERM U1227, Lymphocytes B et Autoimmunité, and LabEx IGO, Brest, France; CHRU Morvan, Laboratoire d'Immunologie, Brest, France., Jamin C; Université de Brest, INSERM U1227, Lymphocytes B et Autoimmunité, and LabEx IGO, Brest, France; CHRU Morvan, Laboratoire d'Immunologie, Brest, France. Electronic address: christophe.jamin@univ-brest.fr.

المصدر: The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2017 Jul; Vol. 140 (1), pp. 215-222. Date of Electronic Publication: 2016 Nov 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Mosby Country of Publication: United States NLM ID: 1275002 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6825 (Electronic) Linking ISSN: 00916749 NLM ISO Abbreviation: J Allergy Clin Immunol Subsets: MEDLINE

مواضيع طبية MeSH: B-Lymphocytes, Regulatory/*immunology , T-Lymphocytes, Helper-Inducer/*immunology, B-Lymphocytes, Regulatory/physiology ; Cell Differentiation ; Cells, Cultured ; Coculture Techniques ; Humans ; Interleukin-12/immunology ; Interleukins/immunology ; T-Lymphocytes, Helper-Inducer/physiology

المؤلفون: Tempescul A; Department of Clinical Haematology, Institute of Oncology and Haematology, CHRU morvan, Brest, France.; INSERM ESPRI ERI29 Laboratory of Immunotherapy and B Cell Diseases, Reseau Epigenetique et Reseau Canaux Ioniques du Cancéropole Grand Ouest, Brest, France., Bagacean C; INSERM ESPRI ERI29 Laboratory of Immunotherapy and B Cell Diseases, Reseau Epigenetique et Reseau Canaux Ioniques du Cancéropole Grand Ouest, Brest, France., Riou C; Department of Clinical Haematology, Institute of Oncology and Haematology, CHRU morvan, Brest, France.; INSERM ESPRI ERI29 Laboratory of Immunotherapy and B Cell Diseases, Reseau Epigenetique et Reseau Canaux Ioniques du Cancéropole Grand Ouest, Brest, France., Bendaoud B; INSERM ESPRI ERI29 Laboratory of Immunotherapy and B Cell Diseases, Reseau Epigenetique et Reseau Canaux Ioniques du Cancéropole Grand Ouest, Brest, France.; Laboratory of Immunology and Immunotherapy, CHRU Morvan, Brest, France., Hillion S; INSERM ESPRI ERI29 Laboratory of Immunotherapy and B Cell Diseases, Reseau Epigenetique et Reseau Canaux Ioniques du Cancéropole Grand Ouest, Brest, France.; Laboratory of Immunology and Immunotherapy, CHRU Morvan, Brest, France., Debant M; INSERM ESPRI ERI29 Laboratory of Immunotherapy and B Cell Diseases, Reseau Epigenetique et Reseau Canaux Ioniques du Cancéropole Grand Ouest, Brest, France., Buors C; Laboratory of Hematology, CHRU Cavale Blanche, Brest, France., Berthou C; Department of Clinical Haematology, Institute of Oncology and Haematology, CHRU morvan, Brest, France.; INSERM ESPRI ERI29 Laboratory of Immunotherapy and B Cell Diseases, Reseau Epigenetique et Reseau Canaux Ioniques du Cancéropole Grand Ouest, Brest, France., Renaudineau Y; INSERM ESPRI ERI29 Laboratory of Immunotherapy and B Cell Diseases, Reseau Epigenetique et Reseau Canaux Ioniques du Cancéropole Grand Ouest, Brest, France.; Laboratory of Immunology and Immunotherapy, CHRU Morvan, Brest, France.

المصدر: European journal of haematology [Eur J Haematol] 2016 Mar; Vol. 96 (3), pp. 229-35. Date of Electronic Publication: 2015 May 20.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609 (Electronic) Linking ISSN: 09024441 NLM ISO Abbreviation: Eur J Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal/*pharmacology , Antineoplastic Agents/*pharmacology , B-Lymphocytes/*drug effects , B-Lymphocytes/*immunology , Complement C4/*immunology , Leukemia, Lymphocytic, Chronic, B-Cell/*immunology, Adolescent ; Adult ; Aged ; Antibodies, Monoclonal/therapeutic use ; Antibodies, Monoclonal, Humanized ; Antineoplastic Agents/therapeutic use ; B-Lymphocytes/metabolism ; Biomarkers ; Child ; Child, Preschool ; Combined Modality Therapy ; Complement C3/immunology ; Female ; Humans ; Immunophenotyping ; Infant ; Leukemia, Lymphocytic, Chronic, B-Cell/genetics ; Leukemia, Lymphocytic, Chronic, B-Cell/metabolism ; Leukemia, Lymphocytic, Chronic, B-Cell/therapy ; Lymphocyte Depletion ; Male ; Middle Aged ; Polymorphism, Genetic ; Receptors, IgG/genetics ; Treatment Outcome ; Young Adult